Lundbeck Mexico GM Oscar Parra discusses raising awareness of depression in Mexico, Lundbeck’s innovative treatments for depression and Alzheimer’s, and managing to navigate the country’s regulatory process to ultimately benefit the patient.
Lifestyle related illnesses are a major problem in Mexico, with 13 million people suffering from diabetes and 71 percent of the population obese or overweight. Less well-known but equally debilitating is depression; how is Lundbeck working to increase awareness about the importance of treating this illness?
While it is true that obesity and diabetes are a tremendous problem for Mexican society, we cannot understate the importance of depression
